Zusammenfassung
Im Pschyrembel wird unter iatrogen „durch den Arzt verursacht“ verstanden, „z.B. infolge diagnostischer oder therapeutischer Einwirkungen“. Eine andere Definition für iatrogene Krankheit („iatrogenic illness“) versteht hierunter allgemein jeden krankhaften Zustand, der aus einer diagnostischen oder irgendeiner therapeutischen Maßnahme folgt. Dies schließt schädigende Ereignisse ein, die nicht als „natürliche Folge“ der Erkrankungen des Patienten anzusehen sind, z.B. Stürze und Dekubitalulzera. Synonym wird auch der Begriff „iatrogene Komplikation“ verwendet. Eine neuere Definition beruht auf der Zugrundelegung von 3 Kriterien:
-
1.
der Kausalität
-
2.
der messbaren Behinderung und
-
3.
der fehlenden Absicht.
Preview
Unable to display preview. Download preview PDF.
Literatur
Ancelin ML, Artero S, Portet F, Dupuy A-M, Touchon J (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332:455–458
Arzneimittelkommission der Deutschen Ärzteschaft (2005) Pharmakovigilanz. Arzneiverordnung in der Praxis, Band 32, Sonderheft 1
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. J Am Med Ass 294:716–724
Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370–376
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. J Am Med Ass 296:1858–1866
Bundesministerium für Familie und Senioren (1992) Hilfe-und Pflegebedarf in Deutschland 1991. Schnellbericht zur Repräsentativerhebung im Rahmen des Forschungsprojekts „Möglichkeiten und Grenzen selbständiger Lebensführung“, durch Infratest Sozialforschung und Infratest Epidemiologie und Gesundheitsforschung, München
Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259
Egger T, Dorman H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 20:769–776
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers Criteria for potentially inappropriate medication in older adults. Arch Intern Med 163:2716–2724
Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW (2003) Adverse drug events in ambulatory care. N Engl J Med 348:1556–1564
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Ass 289:1107–1116
Haynes RB (1982) Einleitung. In: Haynes, Taylor, Sockett (Hrsg) Compliance Handbuch. Übersetzt und bearbeitet von A. Schrey unter Mitarbeit von E.A. Noack. Oldenbourg, München Wien, S 11–18
Haynes RB, Yao X, Degani A et al (2007) Interventions for enhancing medication adherence (review). The Cochrane Library, http://www.thecochranelibrary.com
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877–884
Klein LE, German PS, Levine DM, Feroli ER, Ardery J (1984) Medication problems among outpatients. A study with emphasis on the elderly. Arch Intern Med 144:1185–1188
Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Weite T, Böger RH (2000) Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504–513
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. J Am Med Ass 279:1200–1205
Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324:377–384
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139(2):137–147
National Kidney Foundation (2002) K/DOQI (Kidney Disease Outcome Quality Inititive) clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):1–266
Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabai R, Gambassi (2002) Adverse drug reactions as cause of hospital admisssions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962–1968
Pedone C, Corsonello A, Incalzi RA for The GIFA Investigators (2006) Estimating renal function in older people: a comparison of three formulas. Age Ageing 35:121–126
Renteln-Kruse W von (2000) Iatrogene Störungen. In: Nikolaus T (Hrsg) Klinische Geriatrie. Springer, Berlin Heidelberg New York, S 410–417
Schmiedl S, Szymanski J, Rottenkolber M, Drewelow B, Haase G, Hippius M, Reimann IR, Siegmund W, May K, Haack S, Hasford J, Thürmann PA (2007) Fingerhut — ein alter Hut? Eine Analyse stationärer Aufnahmen durch digitalisassoziierte unerwünschte Arzneimittelwirkungen. Med Klinik 102:603–611
Shelton PS, Fritsch MA, Scott MA (2000) Assessing medication appropriateness in the elderly. A review of available measures. Drugs Aging 16:437–450
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, HanIon JT (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184
Thomas EJ, Brennan TA (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. Br Med J 320:741–747
Tinetti ME, Bogardus ST, Agostini JV (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351:2870–2874
Weingart SN, Wilson RMcL, Gibberd RW, Harrison B (2000) Epidemiology of medical error. Br Med J 320:774–777
Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD (1995) The Quality in Australian Health Care Study. Med J Aust 163:458–471
Wrenger E, Müller R, Moesenthin M, Welte T, Fröhlich JC (2003) Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. Br Med J 327:147–149
Wucherpfennig G, Meier-Baumgartner HP, Görres S (1988) Prospektive Studie zur Digitalisintoxikation in der Geriatrie. Z Geriatrie 1:95–100
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Steinkopff Verlag
About this chapter
Cite this chapter
(2009). Iatrogene Störungen. In: v. Renteln-Kruse, W. (eds) Medizin des Alterns und des alten Menschen. Steinkopff. https://doi.org/10.1007/978-3-7985-1727-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1727-1_6
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1726-4
Online ISBN: 978-3-7985-1727-1
eBook Packages: Medicine (German Language)